{"id":"NCT04501861","sponsor":"The Cleveland Clinic","briefTitle":"Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:","officialTitle":"Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients: a Comparative-effectiveness Quality Project","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-11-05","primaryCompletion":"2023-08-22","completion":"2024-12-31","firstPosted":"2020-08-06","resultsPosted":"2025-01-09","lastUpdate":"2025-03-24"},"enrollment":153,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cardiac Disease"],"interventions":[{"type":"DRUG","name":"Vasopressin","otherNames":[]},{"type":"DRUG","name":"Norepinephrine","otherNames":[]}],"arms":[{"label":"use of vasopressin","type":"ACTIVE_COMPARATOR"},{"label":"use of norepinephrine","type":"ACTIVE_COMPARATOR"}],"summary":"The relative increase in the mPAP with the same unit increase in MAP adjusted for baseline, and RV function assessed by GLS, between VP and NE in patients with normal and increased pulmonary artery pressure, who require vasopressor support during cardiac surgery.","primaryOutcome":{"measure":"mPAP-to-MAP Ratio","timeFrame":"during 20 minute period after chest closure","effectByArm":[{"arm":"The Use of Vasopressin","deltaMin":0.394,"sd":0.086},{"arm":"The Use of Norepinephrine","deltaMin":0.385,"sd":0.094}],"pValues":[{"comp":"OG000 vs OG001","p":"0.53"},{"comp":"OG000 vs OG001","p":"0.26"},{"comp":"OG000 vs OG001","p":"0.88"}]},"eligibility":{"minAge":"19 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}